1. AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Haraoui, B; Massicotte, F; Pelletier, J-P; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗